Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
about
Phosphoprotein phosphatase 2A: a novel druggable target for Alzheimer's diseaseToxin-Induced Experimental Models of Learning and Memory ImpairmentBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseWinning a Won Game: Caffeine Panacea for Obesity SyndemicAnxiety and verbal memory performance in APOE-4 carriers and noncarriers aged 50 years and above.CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer's DiseaseAlzheimer's disease: a healthcare burden of epidemic proportion.A randomized controlled trial investigating the neurocognitive effects of Lacprodan® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: the Phospholipid Intervention for Cognitive AgeiVascular basis for brain degeneration: faltering controls and risk factors for dementia.Spatial reference memory in normal aging Fischer 344 × Brown Norway F1 hybrid rats.Positive effects of soy lecithin-derived phosphatidylserine plus phosphatidic acid on memory, cognition, daily functioning, and mood in elderly patients with Alzheimer's disease and dementiaCRP gene variation affects early development of Alzheimer's disease-related plaques.Clinical Characteristics for the Relationship between Type-2 Diabetes Mellitus and Cognitive Impairment: A Cross-Sectional StudyA correlativity study of plasma APL1β28 and clusterin levels with MMSE/MoCA/CASI in aMCI patients.Obesity diminishes synaptic markers, alters microglial morphology, and impairs cognitive functionHydrogen sulfide, the next potent preventive and therapeutic agent in aging and age-associated diseases.Development of a new method for assessing global risk of Alzheimer's disease for use in population health approaches to prevention.Alterations in cerebrospinal fluid glycerophospholipids and phospholipase A2 activity in Alzheimer's disease.The involvement of homocysteine in stress-induced Aβ precursor protein misprocessing and related cognitive decline in rats.Effects of intermittent aerobic training on passive avoidance test (shuttle box) and stress markers in the dorsal hippocampus of wistar rats exposed to administration of homocysteine.Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil.Application of Metabolomics in Alzheimer's Disease.Treatment with acetyl-L-carnitine exerts a neuroprotective effect in the sciatic nerve following loose ligation: a functional and microanatomical study.CHAT gene polymorphism rs3810950 is associated with the risk of Alzheimer's disease in the Czech population.Aberrant Default Mode Network Underlying the Cognitive Deficits in the Patients With Late-Onset Depression
P2860
Q24627125-738BA2EA-3119-4ABD-91E2-C5C767DE281FQ28075913-C9401F59-4A58-48A3-9754-73C61805DB8EQ28259585-A3787C89-3891-4002-9C88-DB8EDE1115C8Q29540785-F84882C1-9EE9-487E-9048-7A19AFD6F599Q30423533-6054E367-507F-41CA-8A5D-F10226690AFDQ33896118-173F9274-1BC0-4F38-BF56-B17D4049B7C9Q33932371-62FCC9C4-032C-44DB-A44E-D183F3AFCA6FQ34455494-2D7D867E-5B62-4891-8869-E592721A7581Q34680483-5BA22B58-CF92-4AEA-9910-DA3221E605A4Q34715625-78392A15-BAF4-4B46-B2E3-79397839D094Q34737239-DC39BF3E-67DB-4B14-8F1E-26EB9E8D24DFQ35200584-968B4FDE-AAB0-41A0-9C27-DA4C4655D2B8Q35871576-4FC0E85C-A37C-41FF-B574-509F9904FDFCQ36209423-40B3895D-A4E0-4021-BC60-009E990A1147Q36419860-633F3C8E-632C-452F-8913-64009F658157Q36667451-4C769A36-AC43-4DCC-9626-ABBB54F20A63Q36966514-D161DBA3-5AEA-4D6C-8445-4919306F3B4FQ37163086-5CF6DC4D-BB14-4323-B0B9-2D0AD3D78451Q37214865-149D29C0-1AD2-4BDE-A27F-ADC253E77BA0Q37612894-AD6460BE-5A99-4793-A67E-6DDEB007BCA5Q38962796-A17CCDFB-5ED7-4F5C-9030-E630166FC8BCQ39042377-DAB91320-CE12-4C16-832C-AE9A25067DBFQ47146178-92582B73-F56E-4374-8AAD-F161698FA25AQ49464422-31371FD9-13E8-4B85-9B27-42FF1FCF1B54Q55019691-1C6764CB-32D8-412D-A63A-1C4D45DE83ECQ55086922-64D1FBA5-0826-4075-BF9B-69886A12764DQ58585194-18EEF881-1D20-4668-8F04-EEFAED0F3E55
P2860
Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: current understanding and progress toward integrative prevention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Alzheimer's disease, amnestic ...... toward integrative prevention.
@en
Alzheimer's disease, amnestic ...... toward integrative prevention.
@nl
type
label
Alzheimer's disease, amnestic ...... toward integrative prevention.
@en
Alzheimer's disease, amnestic ...... toward integrative prevention.
@nl
prefLabel
Alzheimer's disease, amnestic ...... toward integrative prevention.
@en
Alzheimer's disease, amnestic ...... toward integrative prevention.
@nl
P1476
Alzheimer's disease, amnestic ...... toward integrative prevention
@en
P2093
Parris M Kidd
P304
P577
2008-06-01T00:00:00Z